Here are two stocks with buy rank and strong momentum characteristics for investors to consider today, January 11th:
ADMA Biologics, Inc. (ADMA - Free Report) : This biopharmaceutical company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 33.3% over the last 60 days.
ADMA’s shares gained 55.5% over the last three months compared with the S&P 500’s advance of 8.8%. The company possesses a Momentum Score of A.
Arcutis Biotherapeutics, Inc. (ARQT - Free Report) : This biopharmaceutical company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 10.4% over the last 60 days.
Arcutis’ shares gained 101% over the last month compared with the S&P 500’s advance of 2.5%. The company possesses a Momentum Score of A.
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
(We are reissuing this article to correct a mistake. The original article, issued on January 11, 2024, should no longer be relied upon.)
Top 5 Dividend Stocks for Your Retirement
Zacks targets 5 well-established companies with solid fundamentals and a history of raising dividends. More importantly, they have the resources and will to likely pay them in the future.
Click now for a Special Report packed with unconventional wisdom and insights you simply won’t get from your neighborhood financial planner.
See our Top 5 now – the report is FREE >>
Here are two stocks with buy rank and strong momentum characteristics for investors to consider today, January 11th:
ADMA Biologics, Inc. (ADMA - Free Report) : This biopharmaceutical company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 33.3% over the last 60 days.
ADMA’s shares gained 55.5% over the last three months compared with the S&P 500’s advance of 8.8%. The company possesses a Momentum Score of A.
Arcutis Biotherapeutics, Inc. (ARQT - Free Report) : This biopharmaceutical company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 10.4% over the last 60 days.
Arcutis’ shares gained 101% over the last month compared with the S&P 500’s advance of 2.5%. The company possesses a Momentum Score of A.
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
(We are reissuing this article to correct a mistake. The original article, issued on January 11, 2024, should no longer be relied upon.)
Top 5 Dividend Stocks for Your Retirement
Zacks targets 5 well-established companies with solid fundamentals and a history of raising dividends. More importantly, they have the resources and will to likely pay them in the future.
Click now for a Special Report packed with unconventional wisdom and insights you simply won’t get from your neighborhood financial planner.
See our Top 5 now – the report is FREE >>
Get the latest research report on ADMA - FREE
Get the latest research report on ARQT - FREE